| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,264,075 | 1,266,976 | 1,209,917 | 1,203,155 | | Cost of Revenue | 759,095 | 739,209 | 684,184 | 808,501 | | | Gross Profit | 504,980 | 527,767 | 525,733 | 394,654 | | | Operating Expenses | | Research Development | 69,812 | 74,017 | 58,836 | 77,897 | | Selling General and Administrative | 262,360 | 279,037 | 239,556 | 265,532 | | Non Recurring | 111,530 |
-
|
-
| 16,634 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 61,278 | 174,713 | 227,341 | 34,591 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 243 | 25,309 | 4,189 | (9,246) | | Earnings Before Interest And Taxes | 61,521 | 200,022 | 231,530 | 25,345 | | Interest Expense | 77,034 | 78,173 | 85,002 | 92,256 | | Income Before Tax | (15,513) | 121,849 | 146,528 | (66,911) | | Income Tax Expense | (11,093) | 26,178 | 37,454 | (59,955) | | Minority Interest | (842) | (5,816) |
-
| 1,765 | | | | Net Income From Continuing Ops | (5,262) | 89,855 | 109,074 | (5,191) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,262) | 89,855 | 109,074 | (5,191) | | Preferred Stock And Other Adjustments | (34,758) | (31,743) | (37,775) | (34,799) | | | Net Income Applicable To Common Shares | ($40,020) | $58,112 | $71,299 | ($39,990) |
|
0.22% Nasdaq 
0.21 (1.15%) 
Income Statement
